Akt Determines Cell Fate Through Inhibition of the PERK-eIF2α Phosphorylation Pathway
暂无分享,去创建一个
W. Muller | A. Koromilas | M. Hatzoglou | Z. Mounir | Shuo Wang | J. Krishnamoorthy | Shirley L. Campbell | B. Papadopoulou
[1] Jing Wang,et al. Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence , 2010, Nature.
[2] Jiangbin Ye,et al. PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage , 2010, Oncogene.
[3] S. Formenti,et al. Translational control in cancer , 2010, Nature Reviews Cancer.
[4] G. Robertson,et al. Tumor Suppression by PTEN Requires the Activation of the PKR-eIF2α Phosphorylation Pathway , 2009, Science Signaling.
[5] Pixu Liu,et al. Targeting the phosphoinositide 3-kinase pathway in cancer , 2009, Nature Reviews Drug Discovery.
[6] D. Scheuner,et al. Translation attenuation through eIF2alpha phosphorylation prevents oxidative stress and maintains the differentiated state in beta cells. , 2009, Cell metabolism.
[7] J. Blenis,et al. Molecular mechanisms of mTOR-mediated translational control , 2009, Nature Reviews Molecular Cell Biology.
[8] C. Chresta,et al. Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR) , 2009, The Biochemical journal.
[9] A. Hinnebusch,et al. Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets , 2009, Cell.
[10] N. Hay,et al. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. , 2008, Cancer cell.
[11] B. Wouters,et al. Hypoxia signalling through mTOR and the unfolded protein response in cancer , 2008, Nature Reviews Cancer.
[12] Gary Box,et al. The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer . , 2008, Journal of medicinal chemistry.
[13] Jennifer F. Raven,et al. The eIF2α kinases inhibit vesicular stomatitis virus replication independently of eIF2 phosphorylation. , 2008 .
[14] Jennifer F. Raven,et al. PERK and PKR: Old kinases learn new tricks , 2008, Cell cycle.
[15] C. Lindsley,et al. The PI3K/Akt pathway: recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitors. , 2008, Current cancer drug targets.
[16] J. Pelletier,et al. A Novel Function of eIF2α Kinases as Inducers of the Phosphoinositide-3 Kinase Signaling Pathway , 2007 .
[17] P. Walter,et al. Signal integration in the endoplasmic reticulum unfolded protein response , 2007, Nature Reviews Molecular Cell Biology.
[18] Lewis C. Cantley,et al. AKT/PKB Signaling: Navigating Downstream , 2007, Cell.
[19] Y. Nomura,et al. Akt up- and down-regulation in response to endoplasmic reticulum stress , 2007, Brain Research.
[20] D. Charnock-Jones,et al. Endoplasmic reticulum stress exacerbates ischemia‐reperfusion‐induced apoptosis through attenuation of Akt protein synthesis in human choriocarcinoma cells , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] S. Gruber,et al. Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway , 2006, Nature Cell Biology.
[22] Afshin Samali,et al. Mediators of endoplasmic reticulum stress‐induced apoptosis , 2006, EMBO reports.
[23] J. Diehl,et al. Coordination of ER and oxidative stress signaling: the PERK/Nrf2 signaling pathway. , 2006, The international journal of biochemistry & cell biology.
[24] T. Anthony,et al. Coping with stress: eIF2 kinases and translational control. , 2006, Biochemical Society transactions.
[25] C. Kumar,et al. AKT crystal structure and AKT-specific inhibitors , 2005, Oncogene.
[26] D. Scheuner,et al. ER stress‐regulated translation increases tolerance to extreme hypoxia and promotes tumor growth , 2005, The EMBO journal.
[27] N. Sonenberg,et al. Translational control in stress and apoptosis , 2005, Nature Reviews Molecular Cell Biology.
[28] L. Hendershot,et al. The role of the unfolded protein response in tumour development: friend or foe? , 2004, Nature Reviews Cancer.
[29] P. Hu,et al. Critical Role of Endogenous Akt/IAPs and MEK1/ERK Pathways in Counteracting Endoplasmic Reticulum Stress-induced Cell Death* , 2004, Journal of Biological Chemistry.
[30] James B. Mitchell,et al. Oxidative stress, redox, and the tumor microenvironment. , 2004, Seminars in radiation oncology.
[31] Robert D Cardiff,et al. Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. , 2004, Cancer research.
[32] I. Komuro,et al. Akt-Induced Cellular Senescence: Implication for Human Disease , 2004, Cell cycle.
[33] I. Komuro,et al. Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21‐dependent pathway , 2004, The EMBO journal.
[34] D. Alessi,et al. Insulin-induced Drosophila S6 kinase activation requires phosphoinositide 3-kinase and protein kinase B. , 2003, The Biochemical journal.
[35] Jennifer Skeen,et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. , 2003, Genes & development.
[36] A. Hinnebusch,et al. Translational control by TOR and TAP42 through dephosphorylation of eIF2alpha kinase GCN2. , 2003, Genes & development.
[37] R. Paules,et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. , 2003, Molecular cell.
[38] A. Gingras,et al. Activation of GCN2 in UV-Irradiated Cells Inhibits Translation , 2002, Current Biology.
[39] Stevan R. Hubbard,et al. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA , 2002, Nature.
[40] S. Orkin,et al. Heme‐regulated eIF2α kinase (HRI) is required for translational regulation and survival of erythroid precursors in iron deficiency , 2001, The EMBO journal.
[41] E McEwen,et al. Translational control is required for the unfolded protein response and in vivo glucose homeostasis. , 2001, Molecular cell.
[42] H. Atkins,et al. Characterization of Transgenic Mice with Targeted Disruption of the Catalytic Domain of the Double-stranded RNA-dependent Protein Kinase, PKR* , 1999, The Journal of Biological Chemistry.
[43] D. Ron,et al. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase , 1999, Nature.
[44] A. Bridges,et al. A synthetic inhibitor of the mitogen-activated protein kinase cascade. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[45] N. Naidoo. The Endoplasmic Reticulum Stress Response and Aging , 2009, Reviews in the neurosciences.
[46] C. Lindsley,et al. Recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitors. , 2007, Current topics in medicinal chemistry.
[47] J. Pelletier,et al. A Novel Function of eIF 2 Kinases as Inducers of the Phosphoinositide-3 Kinase Signaling Pathway , 2007 .